Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

December 7, 2016December 7, 2016

Biosimilar Seen to Match Herceptin in Treating Advanced Breast Cancer in Clinical Trial

News

A Phase 3 clinical trial comparing Mylan’s proposed biosimilar trastuzumab with the original Herceptin (trastuzumab) found no difference between the drugs in effectiveness or safety, suggesting that the biosimilar may be a ... Read more

October 31, 2016

New Data on Breastfeeding Hormone May Lead to ‘Revolutionary Path’ Against Triple Negative Breast Cancer

News

Researchers have discovered that high levels of prolactin receptors in triple negative breast cancer makes the tumor much less aggressive. They suggest that breastfeeding, linked to the release of the hormone ... Read more

October 24, 2016October 24, 2016

Mammography More Likely to Lead to Excessive Treatment Than to Save Lives, Study Suggests

News

Mammography screenings may be a less valuable breast cancer-detecting tool than thought. A recent study showed that breast cancer screenings are as likely — if not more so — to detect small ... Read more

October 4, 2016

Mitochondrial DNA Reveals Patients’ Unexpected Ancestry – and Breast Cancer Risk

News

Analyses of mitochondrial DNA in women with triple-negative breast cancer revealed that a significant proportion of these patients may have a different ancestry than they are aware of — influencing ... Read more

September 26, 2016

Blocking Unexplored Breast Cancer Mutations Seen to Largely Stop Metastasis in Mice

News

Targeting often ignored mutations in breast cancer cells with gene therapy largely prevented the formation of metastasis — the one thing that transforms a breast tumor linked to good survival chances into ... Read more

September 12, 2016October 18, 2016

Circulating Breast Cancer Cells Can Switch HER2 Gene On-Off to Evade Treatment

News

In women with metastatic breast cancer who have gone through several rounds of treatment, circulating tumor cells can switch on and off a gene called HER2, allowing them to better ... Read more

September 7, 2016

African-Americans with Breast Cancer Skeptical of Post-Treatment Care, Survey Finds

News

African-American women who survive a breast cancer diagnosis face a variety of challenges, a new study reveals, beginning with a widespread distrust of the medical community. The study, “Post-treatment problems ... Read more

August 17, 2016August 17, 2016

Breast Cancer Mutations Occur in Bursts in Early Tumor Development, Study Shows

News

Mutations called copy number aberrations (CNAs) that drive the development of so-called triple negative breast cancer likely occur in short punctuated bursts at the earliest phases of tumor growth, according ... Read more

July 26, 2016October 18, 2016

Breast Cancer Cells Hijack DNA Process to Fight Effects of Chemotherapy, Study Finds

News

Breast cancer cells with mutations in the BRCA1 or BRCA2 genes can become resistant to chemotherapy drugs by recruiting a host of proteins that protect tumor DNA from damage. Since mutations in ... Read more

July 21, 2016July 21, 2016

Mammatyper Seen to Ably Classify Invasive Breast Cancers, Key to Proper Treatment

News

BioNTech Diagnostics reports that data supporting the superiority of a device called the MammaTyper in classifying newly diagnosed invasive breast cancer has been confirmed by a recently published study. The study, “Biological ... Read more